BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37732463)

  • 1. m
    Ren Y; Li Z; Li J; Liang R; Wang Z; Bai Y; Yang Y; Tang Q; Fu Y; Zhang X; Zhang Y; Yu Y; Xiong Y
    Obes Rev; 2023 Dec; 24(12):e13639. PubMed ID: 37732463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
    Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
    Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine methylation and skin diseases.
    Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
    Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic reversible RNA N
    Bi Z; Liu Y; Zhao Y; Yao Y; Wu R; Liu Q; Wang Y; Wang X
    J Cell Physiol; 2019 Jun; 234(6):7948-7956. PubMed ID: 30644095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The momentous role of N6-methyladenosine in lung cancer.
    Xu R; Pang G; Zhao Q; Yang L; Chen S; Jiang L; Shen Y; Shao W
    J Cell Physiol; 2021 May; 236(5):3244-3256. PubMed ID: 33135190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Adenosine Methylation (m
    Chen YS; Ouyang XP; Yu XH; Novák P; Zhou L; He PP; Yin K
    J Cardiovasc Transl Res; 2021 Oct; 14(5):857-872. PubMed ID: 33630241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenine RNA Modification (m
    Zhong H; Tang HF; Kai Y
    Curr Drug Targets; 2020; 21(11):1056-1067. PubMed ID: 32066359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
    Yue Y; Liu J; He C
    Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of M
    Chen J; Zhang Q; Liu T; Tang H
    Curr Gene Ther; 2022; 22(1):40-50. PubMed ID: 34825870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Zhao Y; Shi Y; Shen H; Xie W
    J Hematol Oncol; 2020 Apr; 13(1):35. PubMed ID: 32276589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
    Meyer KD; Jaffrey SR
    Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Regulation of mRNA m⁶A Modification in Cancer Development.
    Luo J; Liu H; Luan S; He C; Li Z
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149601
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of m
    Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into RNA N6-methyladenosine in Glucose and Lipid Metabolic Diseases and Their Therapeutic Strategies.
    Wu Y; Zeng Y; Ren Y; Yu J; Zhang Q; Xiao X
    Endocrinology; 2023 Nov; 165(1):. PubMed ID: 37950364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.
    Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X
    Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.